My glucose is normal but my insulin is high. What does that mean?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
A high fasting insulin with a normal glucose usually means the pancreas is producing extra insulin to hold glucose in range, which is consistent with insulin resistance. It is not a diagnosis. Fasting insulin has no agreed cut-off, does not appear in the ADA diagnostic criteria, and does not on its own change treatment.
A raised fasting insulin alongside a normal fasting glucose is the pattern people mean when they talk about compensated insulin resistance. The pancreas is producing more insulin than average to keep glucose where it should be. That is a real physiological observation. It is also a soft one, because fasting insulin has no diagnostic threshold agreed by any professional society.
Why there is no agreed cut-off
Insulin is measured by immunoassay, and each laboratory reports results against its own reference interval rather than against a shared diagnostic threshold. The 2026 ADA Standards of Care define prediabetes and diabetes using fasting glucose, two hour glucose on a 75 g load and A1C. Insulin is not part of the criteria, which means no one has validated a number above which treatment is indicated or below which risk is excluded.
What to do with the result
The result is worth something as a prompt. If fasting insulin is high, the follow up questions are whether glucose handling is already abnormal after a meal, whether the liver holds excess fat, and whether the lipid pattern shows the same process. That means a two hour oral glucose tolerance test, ALT and AST, triglycerides and HDL, and a waist measurement. Those tests carry thresholds and lead somewhere.
| Finding | What it suggests | Next step |
|---|---|---|
| High insulin, normal glucose and A1C | Compensation is working | OGTT, liver enzymes, lipids, waist |
| High insulin, two hour glucose 140 to 199 mg/dL | Impaired glucose tolerance | Structured lifestyle program, recheck in 6 months |
| High insulin, raised ALT, high triglycerides | Possible hepatic steatosis | FIB-4 score, liver imaging |
| Low or normal insulin with rising glucose | Falling beta cell output | Consider autoantibodies and C-peptide |
The treatment usually does not change
Here is the part that surprises people: even when fasting insulin is clearly high, the first line response is what it would have been anyway. Weight loss of 5 to 7 percent where there is excess adiposity, 150 minutes a week of moderate activity, resistance training to build the tissue that disposes of most glucose, treatment of sleep apnea, and review of any medication that raises glucose. No drug is licensed to treat a raised fasting insulin.
Ask for the tests that lead to a decision rather than repeating the insulin. A two hour glucose tolerance test, an A1C, liver enzymes and a lipid panel will tell you far more about where you actually stand, and they can be repeated in six to twelve months to show whether anything has changed.
The clinical detail
Fasting insulin reference intervals are assay specific and typically run in the region of 2 to 25 microunits per millilitre, but the interval is descriptive of the population tested, not a risk threshold. Values should therefore be read against the reporting laboratory's own interval rather than a number quoted online.
C-peptide is a more stable marker of endogenous insulin secretion, since it is not extracted by the liver on first pass and has a longer half life, and it is useful when the clinical question is beta cell reserve rather than insulin resistance. In someone with rising glucose and a low or falling C-peptide, autoimmune diabetes should be considered and islet autoantibodies checked. The 2026 ADA Standards recommend standardized islet autoantibody testing in adults whose phenotype overlaps with type 1 diabetes.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Insulin Resistance and Prediabetes. National Institute of Diabetes and Digestive and Kidney Diseases
- 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2026. American Diabetes Association. PMID 41358893
- Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. DOI 10.1007/BF00280883
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.